Hi All,
I've ben reading about the NIH trial and also found the
abstract from last December's ASH conference on the use of Campath use for hypo-MDS.
I fit the criteria, but my university-based transplant doc is very negative on Campath, indicating that it is notorious for activating dormant CMV and EBV and would complicate any future transplant.
I'm not sure I want to go the transplant route, but I'd hate to mess up the prospects for one.
Anyone else had feedback like this?
Thanks.
Greg
__________________
Greg, 59, dx MDS RCMD Int-1 03/10, 8+ & Dup1(q21q31). NIH Campath 11/2010. Non-responder. Tiny telomeres. TERT mutation. Danazol at NIH 12/11. TX independent 7/12. Pancreatitis 4/15. 15% blasts 4/16. DX RAEB-2. Beginning Vidaza to prep for MUD STC. Check out my blog at
www.greghankins.com